Zapping tumors with precision: new study tests SABR for metastatic cancer
NCT ID NCT02933242
First seen Nov 17, 2025 · Last updated May 22, 2026 · Updated 25 times
Summary
This study looks at whether a high-dose, targeted radiation treatment called SABR can safely control cancer that has spread to a few spots in the body (oligometastases). About 400 adults with up to 5 metastatic tumors will receive SABR, and researchers will track side effects, quality of life, and survival. The goal is to see if this approach can help manage the disease without curing it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BC Cancer
Prince George, British Columbia, V2M 7E9, Canada
Conditions
Explore the condition pages connected to this study.